Serum homocysteine increases after therapy with fenofibrate or bezafibrate

被引：108

作者：

Dierkes, J ^{[1
]}

Westphal, S ^{[1
]}

Luley, C ^{[1
]}

机构：

[1] Univ Magdeburg, Inst Clin Chem, D-39120 Magdeburg, Germany

来源：

LANCET | 1999年 / 354卷 / 9174期

关键词：

D O I：

10.1016/S0140-6736(99)02153-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A 44% and 17.5% increase of homocysteine occurred in patients treated either with fenofibrate or bezafibrate. The increase was not explained by changes in vitamin concentrations but may be related to renal function.

引用

页码：219 / 220

页数：2

共 5 条

[1] Lipid-lowering drugs and homocysteine [J].

de Lorgeril, M ;

Salen, P ;

Paillard, F ;

Lacan, P ;

Richard, G .

LANCET, 1999, 353 (9148) :209-210

[2]

Dennis VW, 1996, KIDNEY INT, V50, pS11

[3] CREATININE RISE AFTER FIBRATE THERAPY IN RENAL GRAFT RECIPIENTS [J].

DEVUYST, O ;

GOFFIN, E ;

PIRSON, Y ;

DESTRIHOU, CV .

LANCET, 1993, 341 (8848) :840-840

[4] SEVERE REVERSIBLE RENAL-FAILURE WITH BEZAFIBRATE [J].

LIPKIN, GW ;

TOMSON, CRV .

LANCET, 1993, 341 (8841) :371-371

[5] The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C [J].

Norlund, L ;

Grubb, A ;

Fex, G ;

Leksell, H ;

Nilsson, JE ;

Schenck, H ;

Hultberg, B .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (03) :175-178

← 1 →